全基因组测序和网络建模以克服曲妥珠单抗耐药性。 - Suppr

Suppr

超能文献

Complete genome sequencing and network modeling to overcome trastuzumab resistance.

作者信息

Roukos Dimitrios H

出版信息

Pharmacogenomics. 2010 Aug;11(8):1039-43. doi: 10.2217/pgs.10.104.

DOI:10.2217/pgs.10.104

PMID:20704462

Abstract

摘要

相似文献

Complete genome sequencing and network modeling to overcome trastuzumab resistance.

Pharmacogenomics. 2010 Aug;11(8):1039-43. doi: 10.2217/pgs.10.104.

Can strategies targeting cleaved MUC1 overcome resistance to trastuzumab?

Breast Cancer Res Treat. 2011 Jun;127(2):589-90. doi: 10.1007/s10549-009-0543-6. Epub 2009 Oct 16.

[Herceptin (trastuzumab)].

Gan To Kagaku Ryoho. 2007 Aug;34(8):1173-6.

Not quite pharmacogenomics.

Nat Biotechnol. 1998 Dec;16(13):1295. doi: 10.1038/4244.

ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines.

Oncogene. 2007 Nov 1;26(50):7163-9. doi: 10.1038/sj.onc.1210528. Epub 2007 May 21.

Continuation of trastuzumab beyond disease progression.

J Clin Oncol. 2005 Apr 20;23(12):2866-8; discussion 2868-9. doi: 10.1200/JCO.2005.05.177.

Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.

Int J Oncol. 2007 Oct;31(4):769-76.

Trastuzumab (herceptin) for early-stage breast cancer.

Hematol Oncol Clin North Am. 2007 Apr;21(2):239-56. doi: 10.1016/j.hoc.2007.03.003.

Managing trastuzumab-resistant breast cancer.

Clin Adv Hematol Oncol. 2009 Feb;7(2):108-10.

[Trastuzumab in the breast cancer treatment: efficacy and resistance mechanisms].

Klin Onkol. 2009;22(2):45-51.

引用本文的文献

From single protein to colorectal cancer genome landscape and network biology-based biomarkers.

Surg Endosc. 2013 Aug;27(8):3047-8. doi: 10.1007/s00464-013-2852-4. Epub 2013 Feb 27.

Colorectal cancer liver metastases: advances in minimally invasive surgery and genome sequencing-based discoveries.

Surg Endosc. 2013 May;27(5):1848-50. doi: 10.1007/s00464-012-2650-4. Epub 2012 Dec 13.

GIST: advances in tyrosine kinase inhibitors enhance laparoscopic resection even in advanced disease.

Surg Endosc. 2013 Apr;27(4):1446-7. doi: 10.1007/s00464-012-2599-3. Epub 2012 Oct 24.

Next-generation, genome- and mutational landscape heterogeneity-based novel biomarkers for personalized neoadjuvant treatment and laparoscopic rectal cancer resection.

Surg Endosc. 2013 Apr;27(4):1441-3. doi: 10.1007/s00464-012-2570-3. Epub 2012 Oct 6.

Dynamic imaging in medicine and network biology.

Surg Endosc. 2013 Feb;27(2):689-90. doi: 10.1007/s00464-012-2467-1. Epub 2012 Jul 18.

Expanding laparoscopic gastrectomy for gastric cancer outside Korea and Japan.

Surg Endosc. 2012 Dec;26(12):3700-1. doi: 10.1007/s00464-012-2393-2. Epub 2012 Jun 26.

Predictive medicine and esophageal cancer response to preoperative chemotherapy.

Surg Endosc. 2013 Jan;27(1):347-8. doi: 10.1007/s00464-012-2411-4. Epub 2012 Jun 22.

Risk factors and early detection of breast cancer: facts, questions, and genome-based perspectives.

Curr Oncol. 2012 Jun;19(3):131. doi: 10.3747/co.19.991.

Personalized medicine for laparoscopic gastrectomy in gastric cancer.

Surg Endosc. 2012 Nov;26(11):3352-3. doi: 10.1007/s00464-012-2316-2. Epub 2012 May 2.

The long-term efficacy of laparoscopic surgery in early and advanced gastric cancer.

Surg Endosc. 2012 Dec;26(12):3695-6. doi: 10.1007/s00464-012-2275-7. Epub 2012 Apr 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Complete genome sequencing and network modeling to overcome trastuzumab resistance.

作者信息

Roukos Dimitrios H

出版信息

Pharmacogenomics. 2010 Aug;11(8):1039-43. doi: 10.2217/pgs.10.104.

DOI:10.2217/pgs.10.104

PMID:20704462

Abstract

摘要

相似文献

Complete genome sequencing and network modeling to overcome trastuzumab resistance.

Pharmacogenomics. 2010 Aug;11(8):1039-43. doi: 10.2217/pgs.10.104.

Can strategies targeting cleaved MUC1 overcome resistance to trastuzumab?

Breast Cancer Res Treat. 2011 Jun;127(2):589-90. doi: 10.1007/s10549-009-0543-6. Epub 2009 Oct 16.

[Herceptin (trastuzumab)].

Gan To Kagaku Ryoho. 2007 Aug;34(8):1173-6.

Not quite pharmacogenomics.

Nat Biotechnol. 1998 Dec;16(13):1295. doi: 10.1038/4244.

ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines.

Oncogene. 2007 Nov 1;26(50):7163-9. doi: 10.1038/sj.onc.1210528. Epub 2007 May 21.

Continuation of trastuzumab beyond disease progression.

J Clin Oncol. 2005 Apr 20;23(12):2866-8; discussion 2868-9. doi: 10.1200/JCO.2005.05.177.

Int J Oncol. 2007 Oct;31(4):769-76.

Trastuzumab (herceptin) for early-stage breast cancer.

Hematol Oncol Clin North Am. 2007 Apr;21(2):239-56. doi: 10.1016/j.hoc.2007.03.003.

Managing trastuzumab-resistant breast cancer.

Clin Adv Hematol Oncol. 2009 Feb;7(2):108-10.

[Trastuzumab in the breast cancer treatment: efficacy and resistance mechanisms].

Klin Onkol. 2009;22(2):45-51.

引用本文的文献

From single protein to colorectal cancer genome landscape and network biology-based biomarkers.

Surg Endosc. 2013 Aug;27(8):3047-8. doi: 10.1007/s00464-013-2852-4. Epub 2013 Feb 27.

Colorectal cancer liver metastases: advances in minimally invasive surgery and genome sequencing-based discoveries.

Surg Endosc. 2013 May;27(5):1848-50. doi: 10.1007/s00464-012-2650-4. Epub 2012 Dec 13.

GIST: advances in tyrosine kinase inhibitors enhance laparoscopic resection even in advanced disease.

Surg Endosc. 2013 Apr;27(4):1446-7. doi: 10.1007/s00464-012-2599-3. Epub 2012 Oct 24.

Next-generation, genome- and mutational landscape heterogeneity-based novel biomarkers for personalized neoadjuvant treatment and laparoscopic rectal cancer resection.

Surg Endosc. 2013 Apr;27(4):1441-3. doi: 10.1007/s00464-012-2570-3. Epub 2012 Oct 6.

Dynamic imaging in medicine and network biology.

Surg Endosc. 2013 Feb;27(2):689-90. doi: 10.1007/s00464-012-2467-1. Epub 2012 Jul 18.

Expanding laparoscopic gastrectomy for gastric cancer outside Korea and Japan.

Surg Endosc. 2012 Dec;26(12):3700-1. doi: 10.1007/s00464-012-2393-2. Epub 2012 Jun 26.

Predictive medicine and esophageal cancer response to preoperative chemotherapy.

Surg Endosc. 2013 Jan;27(1):347-8. doi: 10.1007/s00464-012-2411-4. Epub 2012 Jun 22.

Risk factors and early detection of breast cancer: facts, questions, and genome-based perspectives.

Curr Oncol. 2012 Jun;19(3):131. doi: 10.3747/co.19.991.

Personalized medicine for laparoscopic gastrectomy in gastric cancer.

Surg Endosc. 2012 Nov;26(11):3352-3. doi: 10.1007/s00464-012-2316-2. Epub 2012 May 2.

The long-term efficacy of laparoscopic surgery in early and advanced gastric cancer.

Surg Endosc. 2012 Dec;26(12):3695-6. doi: 10.1007/s00464-012-2275-7. Epub 2012 Apr 27.